IFNG and COVID-19: Notably, when we assessed immune responses using ELISpot assays, no differences were observed in IFN-γ secretion from PBMCs stimulated with ancestral and JN.1 variants in the COVID-19-naïve group, suggesting that other cells may contribute to IFN-γ production, such as natural killer (NK) cells.